InsidersTradesSigma
Browse the complete record of transactions filed by Marvin Donald, Chief Financial Officer. Officer active across 1 companies, notably Chemomab Therapeutics Ltd.. In total, 2 filings have been logged. Total volume traded: €2k. The latest transaction was filed on 16 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Donald Marvin is the Executive Vice President, Chief Financial Officer, and Chief Operating Officer at Chemomab Therapeutics Ltd., a biopharmaceutical company. He is responsible for financial management and operations of the company. With a strong background in the biopharmaceutical sector, Donald plays a key role in optimizing financial performance and implementing growth strategies. His expertise in finance and operations management is essential to support Chemomab's mission.